Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation

J Clin Invest. 1990 Jun;85(6):1909-13. doi: 10.1172/JCI114653.

Abstract

In previous studies, IL-4 has been reported to interfere with IL-2-driven generation of lymphokine-activated killer (LAK) activity. In this investigation, we have demonstrated that IL-4 inhibited the IL-2-induced differentiation of large granular lymphocytes (LGL) into LAK effectors by a mechanism involving, at least in part, an increase in LGL intracellular cAMP levels. In contrast, with its capacity to induce cAMP accumulation in resting LGL, IL-4 had a very negligible effect on LAK activity induction, and cAMP levels increase in LGL that had been preincubated with IL-2. Furthermore, the inhibitory effect of IL-4 on LAK activity generation also correlated with a marked decrease in N-CBZ-L-lysine thiobenzylester esterase activity, with an inhibition of tumor necrosis factor (TNF) mRNA expression and TNF production by IL-2-stimulated LGL. These results strongly suggest that complex signaling processes could be ascribed to the dual activities of cytokines and their interplay in LAK promotion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation / drug effects
  • Cyclic AMP / physiology*
  • Esterases / metabolism
  • Gene Expression / drug effects
  • Humans
  • Interleukin-2 / pharmacology*
  • Interleukin-4 / physiology*
  • Killer Cells, Lymphokine-Activated / physiology*
  • Lymphocyte Activation / drug effects
  • RNA, Messenger / genetics
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-2
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • Cyclic AMP
  • Esterases
  • serine esterase